| ASSET | YEAR | % RETURN |
|---|---|---|
Tidewater (TDW) | 2017 | -78.32% |
Civitas Resources (CIVI) | 2017 | -76.45% |
Magnite (MGNI) | 2017 | -75.07% |
Xenon Pharmaceuticals (XENE) | 2017 | -63.55% |
Eldorado Gold (EGO) | 2017 | -55.77% |
Soleno Therapeutics (SLNO) | 2017 | -55.59% |
Ocular Therapeutix (OCUL) | 2017 | -47.95% |
Now (DNOW) | 2017 | -47.15% |
Zymeworks Inc Common Stock (ZYME) | 2017 | -43.75% |
Mattel (MAT) | 2017 | -42.11% |
Advance Auto Parts (AAP) | 2017 | -41.5% |
Baytex Energy (BTE) | 2017 | -40.36% |
Signet Jewelers (SIG) | 2017 | -39.28% |
Impinj (PI) | 2017 | -38.91% |
SM Energy (SM) | 2017 | -37.76% |
ADMA Biologics (ADMA) | 2017 | -37.43% |
Centrus Energy (LEU) | 2017 | -37.25% |
DRDGOLD Limited ADR (DRD) | 2017 | -37.01% |
Argan (AGX) | 2017 | -36.51% |
Tecnoglass (TGLS) | 2017 | -36.24% |
Acm Research (ACMR) | 2017 | -35.74% |
Cidara Therapeutics (CDTX) | 2017 | -35.24% |
Ultragenyx (RARE) | 2017 | -35.02% |
Frontline (FRO) | 2017 | -34.62% |
Grupo Simec SAB de CV ADR (SIM) | 2017 | -34.43% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
